Metraipolis › archive › dc_ab900af1ca4a
Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation — Europe PMC PMID:42256242
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42256242
- DOI
- 10.1016/j.jhlto.2026.100594
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T09:19:18.340Z
- SHA-256 of the archived text
61b38530241be2cac618c2674ae58b97b59e0c819f902d841c8159263cd1e36c- Stable URL of this page
https://metraipolis.com/documento/dc_ab900af1ca4a
How to cite
Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation — Europe PMC PMID:42256242 — Europe PMC (en), https://europepmc.org/article/MED/42256242 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab900af1ca4a (Metraipolis archive dc_ab900af1ca4a, sha256 61b38530241be2cac618c2674ae58b97b59e0c819f902d841c8159263cd1e36c)
BibTeX
@misc{dcab900af1ca4a,
title = {Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation — Europe PMC PMID:42256242},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42256242},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab900af1ca4a; sha256 61b38530241be2cac618c2674ae58b97b59e0c819f902d841c8159263cd1e36c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42256242. Agents can read the archived copy with the MCP tool read_document.